Number of Shares
418,858.00
Current Holdings Value*
kr14.11 Mil
% of Portfolio
2.66%
Total Estimate Gain
kr190.63 Mil
% of Total Estimate Gain
48.92%

CTIVP - Lazard International Equity Advantage Fund's Novo Nordisk AS Holding Summary

As of 2021-03-31, COLUMBIA FUNDS VARIABLE INSURANCE TRUST held 418,858.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr14.11 Mil. This investment constitutes 2.66% of their stock portfolio, and COLUMBIA FUNDS VARIABLE INSURANCE TRUST now holds 0.01% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. In addition, there have been 4 sales at an average price of kr217.29 for 1.87 Mil shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, CTIVP - Lazard International Equity Advantage Fund's estimated gain on his OCSE:NOVO B holdings is kr190.63 Mil, reflecting a 48.92% gain to date.

CTIVP - Lazard International Equity Advantage Fund OCSE:NOVO B (kr414.60) Holding Chart

CTIVP - Lazard International Equity Advantage Fund OCSE:NOVO B (kr414.60) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1